The European Master in Clinical Linguistics (EMCL) is a research Master’s programme that offers students specialist training in clinical linguistics, neurolinguistics and psycholinguistics. We fund highly talented and motivated students to carry out original research and prepare them to be widely employable in academia (PhD) and/or the industry (e.g. neurotechnology, clinical sector).

English

Faculty of Psychology and Educational Sciences

Master's Programme

What will you study?

The European Master in Clinical Linguistics (EMCL) is an Erasmus Mundus Joint Master’s Degree (EMJMD) that has been running for over twenty years. The newest edition is offered by the University of Eastern Finland (Finland), Ghent University (Belgium) and the University of Groningen (The Netherlands). We also collaborate with twenty-six excellent associated partners.

At the University of Eastern Finland, the main focus is on speech technology and programming with Python, including both fundamental theory and methods, as well as their application to the assessment of, and adaptive solutions for, speech impairments. At Ghent University students are familiarised with advanced topics in statistics and psycholinguistics, including bilingualism, dyslexia, and eye tracking. Finally, at the University of Groningen the emphasis is on crosslinguistic studies of language-impaired children and adults, language testing in neurosurgical settings, and the usage of neurotechnology and IT for the diagnosis and treatment of language impairments.

In addition, we have the support of twenty-six associated partners, of which twelve are in the academic sector, five in R&D/neurotechnology, and nine in the clinical sector - for further details, take a look at this overview.

In every cohort, we welcome about twenty students from all over the world. Staggered across two years, our students receive training at each of the academic partners, do a mandatory work placement at one of the associated partners, and write an original Master’s dissertation. After graduation, 70% of our students continue to do research in PhD programmes. Since 2017, we have furthermore seen an increasing number of our alumni pursue R&D and clinical careers, making our programme competitive on the international market.